International Clinical Trial: Phase I Clinical Trial to Evaluate the Relative Bioavailability and Food Effect of the New Formulation of HBW-004285 Tablets in Healthy Subjects

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115630) titled 'Phase I Clinical Trial to Evaluate the Relative Bioavailability and Food Effect of the New Formulation of HBW-004285 Tablets in Healthy Subjects' on Dec. 29, 2025.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: Clinical Trial Center of the Third Xiangya Hospital of Central South University

Condition: Pain

Intervention: Group A:For subjects in Group A: In the first cycle, take 2 tablets of the 100 mg formulation under fasting conditions In the second cycle, take 1 tablet of the 200 mg formulation under fasting conditions In the third cycle, take 1 tablet of the 200 mg formulation...